Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Traws Pharma, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 0 | 24 | +24 |
| Shares | 0 | 1.57M | +1.57M |
| Value | $0 | $10.9M | +$10.9M |
New holders (24)
Institutions that held Traws Pharma, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 680,618 | $4.72M | 0.00% |
| BlackRock Inc. | 251,397 | $1.74M | 0.00% |
| Geode Capital Management, LLC | 142,980 | $990.0K | 0.00% |
| State Street Corp | 115,090 | $798.0K | 0.00% |
| Morgan Stanley | 106,786 | $740.0K | 0.00% |
| Dimensional Fund Advisors LP | 73,387 | $509.0K | 0.00% |
| Northern Trust Corp | 32,298 | $224.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 24,930 | $173.0K | 0.00% |
| Marshall Wace, LLP | 24,345 | $169.0K | 0.00% |
| Beacon Pointe Advisors, LLC | 23,987 | $166.0K | 0.01% |
| Ikarian Capital, LLC | 23,226 | $161.0K | 0.03% |
| Jump Financial, LLC | 18,500 | $128.0K | 0.01% |
| Hillcrest Wealth Advisors - NY, LLC | 16,704 | $116.0K | 0.07% |
| Deutsche Bank AG | 16,359 | $113.0K | 0.00% |
| Two Sigma Advisers, LP | 15,633 | $108.0K | 0.00% |
| UBS Group AG | 3,930 | $27.0K | 0.00% |
| Emfo, LLC | 3,333 | $23.0K | 0.02% |
| Rockefeller Capital Management L.P. | 566 | $3.00K | 0.00% |
| Wells Fargo & Company | 103 | $1.00K | 0.00% |
| Bank of America Corp | 39 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 42 | $0 | 0.00% |
| Ironwood Financial, llc | 15 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 4 | $0 | 0.00% |
| Larson Financial Group LLC | 66 | $0 | 0.00% |
Sold out (0)
Institutions that held Traws Pharma, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.